Welcome to our dedicated page for ETRACS Whitney US Critical Technologies ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UBS AG filings for WUCT document foreign private issuer reporting and securities-offering disclosures for the ETRACS Whitney US Critical Technologies ETN. The record includes Form 6-K reports, Form 20-F references, IFRS consolidated financial information, capitalization disclosures, and debt and equity presentation for UBS AG and its subsidiaries.
Registration-related filings also incorporate Form F-3 materials and legal opinion exhibits for UBS AG securities offerings. These disclosures address the issuer's reporting framework, capital structure, funding from UBS Group AG, and the formal documentation supporting registered securities.
UBS (NYSE:WUCT) filed a 424B2 prospectus supplement on June 28, 2025 for its Trigger Autocallable Contingent Yield Notes linked to Delta Air Lines common stock, maturing June 30, 2026.
- Issue price: $10 per note; minimum purchase 100 notes.
- Contingent coupon rate: 15.93%–17.19% per annum, payable quarterly when Delta’s share price is ≥ 75% of the initial level.
- Automatic call: Early redemption at principal plus coupon if Delta’s price is ≥ the initial level on any observation date.
- Downside protection: Full principal returned at maturity only if the share price is ≥ 70% of the initial level; below that, repayment falls in line with the share’s decline, potentially to zero.
- Estimated initial value: $9.55–$9.80 per note, reflecting issuer funding and structuring costs.
- Key dates: Trade 26-Jun-2025, settlement 30-Jun-2025, final valuation 26-Jun-2026, maturity 30-Jun-2026.
- Proceeds to UBS: $9.85 per note after a $0.15 underwriting discount.
The supplement highlights significant credit, market and liquidity risks: investors may receive few or no coupons, face loss of some or all principal, and have limited secondary-market options. The notes are unsecured, unsubordinated obligations of UBS and are not FDIC-insured.